Chromic Phosphate P 32

CHEMBL1200676 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
148.0 g/mol
LogP
Phase
4

A radioactive form of chromic phosphate containing phosphorus-32 used as an intraperitoneal or intrapleural radiotherapy agent to treat malignant ascites and pleural effusions associated with cancers such as ovarian and certain lung cancers. The beta radiation emitted by P-32 destroys tumor cells lining the cavity. Careful instillation technique is required to achieve uniform distribution.

分子量

147.9680 g/mol

TPSA

86.30 Ų

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[O-][32P](=O)([O-])[O-].[Cr+3]

InChI

InChI=1S/Cr.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+3;/p-3/i;5+1

Molecular Formula

CrO4P

HBD / HBA

- / 4

回転可能結合数

0

重原子数

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A radioactive form of chromic phosphate containing phosphorus-32 used as an intraperitoneal or intrapleural radiotherapy agent to treat malignant ascites and pleural effusions associated with cancers such as ovarian and certain lung cancers. The beta radiation emitted by P-32 destroys tumor cells lining the cavity. Careful instillation technique is required to achieve uniform distribution.

Yes, Chromic Phosphate P 32 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200676. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71383. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.